Journal of the Korean Ophthalmological Society 1996;37(7):1095-1104.
Published online July 1, 1996.
A Clinical Study of Risk Factors of Graft Rejection for Penetrating Keratoplasty.
Yoon Won Myong, Sang Wroul Song, Chan Ki Park
Department of Ophthalmology, St. Mary's Hospital, Catholic University, Medical College, Seoul, Korea.
각막이식후 거부반응에 대한 위험요소의 임상적 고찰
명윤원(Yoon Won Myong),송상률(Sang Wroul Song),박찬기(Chan Ki Park)
Abstract
Penetrating keratoplasty was performed on 185 eyes. We analyzed the relative risk about the high and low risk groups, sex, age, complication, neovascularization, and graft size. In 185 grafts, graft rejection was developed in 60 eyes(32.4%). In the low risk group, there was the most graft rejection in 17 keratoconus eyes(62.9%) and in the high risk group, in 18 eyes with vascularized corneal scar. Graft rejection was developed in 33 eyes(47.8%) of the high risk group and developed in 27 eyes(23.3%) of the low risk group. The high risk group increased the risk of graft rejection(Relative risk=3.022, P value=0.001). Graft rejection developed in 33 eyes(25%) with non-vascularization and in 27 eyes(52%) with neovascularization. Neovascularization increased the risk of graft rejection (Relative risk=3.273, P value<0.001). Loosening suture and neovascularization were the most common post-operative complications in 68 eyes, and in the graft size, the range from 7.5 to 7.9 mm, was the most rejection graft size. Sex, age, post-operative complication, and graft size were not maintained with association with graft rejection(P value >0.5). Mean preoperative visual acuity was 0.048 and mean postoperative visual acuity was 0.4. In the high risk group the mean postoperative corrected visual acuity was 0.25 and in the low risk group it was 0.5.
Key Words: graft rejection;high risk group;neovascularization


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next